Back to SO SOROS FUND MANAGEMENT LLC
CEREShowing 1 of 3 quarters
Position history for SOSOROS FUND MANAGEMENT LLC's holdings in CEREVEL THERAPEUTICS HLDNG I
As of its Q2 2024 13F, Soros Fund Management held 2,151,641 shares of CERE (Cerevel Therapeutics Hldng), worth $88M. Soros Fund Management's 13F filings listed CERE from Q1 2024 to Q2 2024, 2 quarterly filings. CERE was 1.6% of Soros Fund Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of CERE: FMR LLC